IRVINE, Calif., Sept. 1, 2015 /PRNewswire/ -- Edwards
Lifesciences Corporation (NYSE: EW), the global leader in the
science of heart valves and hemodynamic monitoring, is scheduled to
present at the 10th Annual Wells Fargo Healthcare Conference at the
Hyatt Regency Boston in Boston,
Massachusetts on Wednesday, September
9, 2015.
Michael A. Mussallem, Edwards
Lifesciences' chief executive officer, is scheduled as the keynote
lunch speaker followed by a company discussion with conference
attendees at 10:10 a.m. PDT
(1:10 p.m. EDT). A live webcast of
the company discussion will be available to all interested parties
on the Edwards Lifesciences investor relations website at
http://ir.edwards.com/events.cfm. Following the discussion, an
archived version of the webcast will be available on the Edwards
investor relations website in the News and Events section, and via
the Edwards Lifesciences Investor Relations App for mobile
devices.
About Edwards Lifesciences
Edwards Lifesciences is the global leader in the science of
heart valves and hemodynamic monitoring. Driven by a passion
to help patients, the company partners with clinicians to develop
innovative technologies in the areas of structural heart disease
and critical care monitoring that enable them to save and enhance
lives. Additional company information can be found at
www.edwards.com.
Edwards, Edwards Lifesciences, and the stylized E logo are
trademarks of Edwards Lifesciences Corporation.
Logo - http://photos.prnewswire.com/prnh/20140714/126903
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/edwards-lifesciences-to-present-at-the-10th-annual-wells-fargo-healthcare-conference-300135618.html
SOURCE Edwards Lifesciences Corporation